XN4.F BIG PHARMA SPLIT CL.A

Financial Services Capital Markets Frankfurt Exchange
10.39 EUR
Close of Nov 12, 2026
7.24 10.10
Market cap
EUR 12.6M
P/E
-
P/B
1.04x
ROE
27.5%
Dividend yield
10.98%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is XN4.F undervalued?

Graham number

The Graham number of BIG PHARMA SPLIT CL.A cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BIG PHARMA SPLIT CL.A fundamental analysis

No fundamental analysis for BIG PHARMA SPLIT CL.A yet.

BIG PHARMA SPLIT CL.A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BIG PHARMA SPLIT CL.A

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.

Full company profile